Elucidating the regulatory mechanisms of Nrf2 sensitivity to ferroptosis in lung cancer cells under cysteine or glucose limitation may lead to novel therapeutic strategies in the clinical management of NSCLC. Here, NFE2L2 is linked to lung cancer.